Brief Title
Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy
Official Title
Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy: A Randomized Prospective Trial
Brief Summary
This study will compare Single Incision Laparoscopic Surgery (SILS) cholecystectomy to traditional laparoscopic cholecystectomy (LC), focusing on patient-reported outcomes and cost.
Detailed Description
Single-Incision Laparoscopic Surgery (SILS) is accepted as a form of surgical treatment. Traditional laparoscopic cholecystectomy (TLC) is well tolerated, with a low complication risk and high patient satisfaction; thus a SILS procedure needs to be at least equivalent to be a justifiable replacement, and should not result in higher costs.
Study Type
Interventional
Primary Outcome
Cost associated with performance of the procedure and post-operative care until discharge
Secondary Outcome
Pain scale reported by patient at discharge, 24 and 48 hours
Condition
Biliary Dyskinesia
Intervention
Single-Incision Laparoscopic Surgery cholecystectomy
Study Arms / Comparison Groups
Single-Incision Laparoscopic Cholecsytectomy (SILS)
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
87
Start Date
February 2010
Completion Date
January 2012
Primary Completion Date
January 2012
Eligibility Criteria
Inclusion Criteria: - Patient recommended to undergo cholecystectomy - Patient age 18-80 - Patient competent to give his/her own informed consent - Patient speaks English without the need for an interpreter Exclusion Criteria: - Additional procedures planned during same surgery - Patient deemed inappropriate for TLC or SILS cholecystectomy
Gender
All
Ages
18 Years - 80 Years
Accepts Healthy Volunteers
No
Contacts
Kimberly M Brown, BS, MD, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT01195285
Organization ID
09-423
Study Sponsor
Saint Luke's Health System
Collaborators
Tyco Healthcare Group LP (d/b/a Covidien)
Study Sponsor
Kimberly M Brown, BS, MD, Principal Investigator, Saint Luke's Hospital of Kansas City
Verification Date
August 2011